NEW YORK, Sept. 17, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Athlete's Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019
http://www.reportlinker.com/p0787708/Athlete's-Foot-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2019.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy
Athlete's Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Summary
GlobalData, the industry analysis specialist, has released its new report, "Athlete's Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019". The report is an essential source of information and analysis on the global Athlete's Foot Therapeutics market. The report identifies the key trends shaping and driving the global Athlete's Foot Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Athlete's Foot Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
The report provides information on the key drivers and challenges of the Athlete's Foot Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Athlete's Foot Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Athlete's Foot Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Athlete's Foot Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Athlete's Foot Therapeutics market
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Athlete's Foot Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Athlete's Foot Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What's the next big thing in the global Athlete's Foot Therapeutics market landscape? – Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Athlete's Foot Therapeutics - Introduction 7
2.1 Disease Overview 7
2.2 Epidemiology 8
2.3 Etiology 8
2.4 Pathophysiology 9
2.5 Signs and Symptoms 9
2.6 Diagnosis 9
2.7 Treatment and Management Options 10
2.8 GlobalData Pipeline Report Guidance 11
3 Athlete's Foot Therapeutics - Market Characterization 12
3.1 Athlete's Foot Therapeutics Market Size (2006-2011) - Global 12
3.2 Athlete's Foot Therapeutics Market Forecast (2011-2019) - Global 13
3.3 Athlete's Foot Therapeutics Market Size (2006-2011) - The US 14
3.4 Athlete's Foot Therapeutics Market Forecast (2011-2019) - The US 15
3.5 Athlete's Foot Therapeutics Market Size (2006-2011) - France 16
3.6 Athlete's Foot Therapeutics Market Forecast (2011-2019) - France 17
3.7 Athlete's Foot Therapeutics Market Size (2006-2011) - Germany 18
3.8 Athlete's Foot Therapeutics Market Forecast (2011-2019) - Germany 19
3.9 Athlete's Foot Therapeutics Market Size (2006-2011) - Italy 20
3.10 Athlete's Foot Therapeutics Market Forecast (2011-2019) - Italy 21
3.11 Athlete's foot Therapeutics Market Size (2006-2011) - Spain 22
3.12 Athlete's Foot Therapeutics Market Forecast (2011-2019) - Spain 23
3.13 Athlete's Foot Therapeutics Market Size (2006-2011) - The UK 24
3.14 Athlete's Foot Therapeutics Market Forecast (2011-2019) - The UK 25
3.15 Athlete's Foot Therapeutics Market Size (2006-2011) - Japan 26
3.16 Athlete's Foot Therapeutics Market Forecast (2011-2019) - Japan 27
3.17 Drivers and Barriers for the Athlete's Foot Therapeutics Market 28
3.17.1 Drivers for the Athlete's Foot Therapeutics Market 28
3.17.2 Barriers for the Athlete's Foot Therapeutics Market 28
3.18 Opportunity and Unmet Need Analysis 29
3.19 Key Takeaway 29
4 Athlete's Foot Therapeutics - Competitive Assessment 30
4.1 Overview 30
4.2 Strategic Competitor Assessment 30
4.3 Product Profiles for the Major Marketed Product Classes in the Athlete's Foot Therapeutics Market 31
4.4 Key Takeaway 32
5 Athlete's Foot Therapeutics - Pipeline Assessment 33
5.1 Overview 33
5.2 Strategic Pipeline Assessment 33
5.3 Athlete's Foot Therapeutics Pipeline - Pipeline by Phases of Development 33
5.3.1 Athlete's Foot Therapeutics - Phase III Pipeline 34
5.3.2 Athlete's Foot Therapeutics - Phase II Pipeline 34
5.3.3 Athlete's Foot Therapeutics - Phase I Pipeline 34
5.3.4 Athlete's Foot Therapeutics - Pre-Clinical Pipeline 34
5.3.5 Technology Trends Analytic Framework 35
5.4 Athlete's Foot Therapeutics Market - Clinical Pipeline by Mechanism of Action 37
5.5 Athlete's Foot Therapeutics - Promising Drugs Under Clinical Development 38
5.6 Molecule Profiles for Promising Drugs in Clinical Development 38
5.6.1 Nitric Oxide 38
5.7 Key Takeaway 39
6 Athlete's Foot Therapeutics - Clinical Trials Mapping 40
6.1 Clinical Trials by Region/Country (The US, EU5 and Japan) 40
6.2 Clinical Trials by Phase 41
6.3 Clinical Trials by Trial Status 42
6.4 Prominent Sponsors 43
6.5 Clinical Trials by Overall Sponsors 44
6.6 Top Companies Participating in Athlete's Foot Therapeutics Clinical Trials 45
7 Athlete's Foot Therapeutics - Strategic Assessment 46
7.1 Key Events Impacting the Future Market 46
7.2 Athlete's Foot Therapeutics: Implications for Future Market Competition 47
8 Athlete's Foot Therapeutics - Future Companies 48
8.1 Introduction 48
8.2 Company Profiles 49
8.2.1 Quinnova Pharmaceuticals, Inc. 49
8.2.2 Nitric Biotherapeutics, Inc. 49
8.2.3 Anacor Pharmaceuticals, Inc. 50
8.2.4 Other Companies in Market 51
9 Athlete's Foot Therapeutics - Licensing and Partnership Deals 52
10 Athlete's Foot Therapeutics - Appendix 53
10.1 Market Definitions 53
10.2 Abbreviations 53
10.3 Methodology 54
10.3.1 Coverage 54
10.3.2 Secondary Research 54
10.3.3 Forecasting 55
10.3.4 Primary Research 58
10.3.5 Expert Panel Validation 58
10.4 Contact Us 58
10.5 Disclaimer 58
10.6 Bibliography 59
1.1 List of Tables
Table 1: Prevalence of Athlete's Foot in the US, EU5 and Japan 8
Table 2: Athlete's Foot Therapeutics Market, Global, Revenue ($m), 2006-2011 12
Table 3: Athlete's Foot Therapeutics Market, Global, Forecast ($m), 2011-2019 13
Table 4: Athlete's Foot Therapeutics Market, The US, Revenue ($m), 2006-2011 14
Table 5: Athlete's Foot Therapeutics Market, The US, Forecast ($m), 2011-2019 15
Table 6: Athlete's Foot Therapeutics Market, France, Revenue ($m), 2006-2011 16
Table 7: Athlete's Foot Therapeutics Market, France, Forecast ($m), 2011-2019 17
Table 8: Athlete's Foot Therapeutics Market, Germany, Revenue ($m), 2006-2011 18
Table 9: Athlete's Foot Therapeutics Market, Germany, Forecast ($m), 2011-2019 19
Table 10: Athlete's Foot Therapeutics Market, Italy, Revenue ($m), 2006-2011 20
Table 11: Athlete's Foot Therapeutics Market, Italy, Forecast ($m), 2011-2019 21
Table 12: Athlete's Foot Therapeutics Market, Spain, Revenue ($m), 2006-2011 22
Table 13: Athlete's Foot Therapeutics Market, Spain, Forecast ($m), 2011-2019 23
Table 14: Athlete's Foot Therapeutics Market, The UK, Revenue ($m), 2006-2011 24
Table 15: Athlete's Foot Therapeutics Market, The UK, Forecast ($m), 2011-2019 25
Table 16: Athlete's Foot Therapeutics Market, Japan, Revenue ($m), 2006-2011 26
Table 17: Athlete's Foot Therapeutics Market, Japan, Forecast ($m), 2011-2019 27
Table 18: Athlete's Foot Therapeutics - Phase II Pipeline, as of November,2011 34
Table 19: Athlete's Foot Therapeutics - Phase II Pipeline, 2011 34
Table 20: Athlete's Foot Therapeutics - Phase I Pipeline, 2011 34
Table 21: Athlete's Foot Therapeutics - Pre-Clinical Pipeline, 2011 34
Table 22: Athlete's Foot Therapeutics -Promising Drugs Under Clinical Development, 2011 38
Table 23: Athlete's Foot Therapeutics Market - Clinical Trials by Region/Country, 2011 40
Table 24: Athlete's Foot Therapeutics - Clinical Trials by Phase, 2011 41
Table 25: Athlete's Foot Therapeutics - Clinical Trials by Status, 2011 42
Table 26: Athlete's Foot Therapeutics -Prominent Sponsors, 2011 43
Table 27: Athlete's Foot Therapeutics - Overall Sponsors, 2011 44
Table 28: Athlete's Foot Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2011 45
Table 29: Quinnova Pharmaceuticals, Inc. Infectious Disease Pipeline, 2011 49
Table 30: Nitric Biotherapeutics, Inc. - Infectious Disease Pipeline Products, 2011 49
Table 31: Anacor Pharmaceuticals - Infectious Disease Pipeline, 2011 50
Table 32: Athlete's Foot Therapeutics Market - Future Companies 51
Table 33: Athlete's Foot Therapeutics, Global, Deals 52
List of Figures
Figure 1: Athlete's Foot 7
Figure 2: Athlete's Foot Therapeutics Market, Global, Revenue ($m), 2006-2011 12
Figure 3: Athlete's Foot Therapeutics Market, Global, Forecast ($m), 2011-2019 13
Figure 4: Athlete's Foot Therapeutics Market, The US, Revenue ($m), 2006-2011 14
Figure 5: Athlete's Foot Therapeutics Market, The US, Forecast ($m), 2011-2019 15
Figure 6: Athlete's Foot Therapeutics Market, France, Revenue ($m), 2006-2011 16
Figure 7: Athlete's Foot Therapeutics Market, France, Forecast ($m), 2011-2019 17
Figure 8: Athlete's Foot Therapeutics Market, Germany, Revenue ($m), 2006-2011 18
Figure 9: Athlete's Foot Therapeutics Market, Germany, Forecast ($m), 2011-2019 19
Figure 10: Athlete's Foot Therapeutics Market, Italy, Revenue ($m), 2006-2011 20
Figure 11: Athlete's Foot Therapeutics Market, Italy, Forecast ($m), 2011-2019 21
Figure 12: Athlete's Foot Therapeutics Market, Spain, Revenue ($m), 2006-2011 22
Figure 13: Athlete's Foot Therapeutics Market, Spain, Forecast ($m), 2011-2019 23
Figure 14: Athlete's Foot Therapeutics Market, The UK, Revenue ($m), 2006-2011 24
Figure 15: Athlete's Foot Therapeutics Market, The UK, Forecast ($m), 2011-2019 25
Figure 16: Athlete's Foot Therapeutics Market, Japan, Revenue ($m), 2006-2011 26
Figure 17: Athlete's Foot Therapeutics Market, Japan, Forecast ($m), 2011-2019 27
Figure 18: Opportunity and Unmet Need in the Athlete's Foot Therapeutics Market, 2011 29
Figure 19: Athlete's Foot Therapeutics - Strategic Competitor Assessment, 2011 31
Figure 20: Athlete's Foot Therapeutics - Pipeline by Phase of Development, 2011 33
Figure 21: Athlete's Foot Therapeutics - Technology Trends Analytics Framework, 2011 35
Figure 22: Athlete's Foot Therapeutics - Technology Trends Analytics Framework - Description, 2011 36
Figure 23: Athlete's Foot Therapeutics - Pipeline by Mechanism of Action, 2011 37
Figure 24: Athlete's Foot Therapeutics - Clinical Trials by Country, 2011 40
Figure 25: Athlete's Foot Therapeutics - Clinical Trials by Phase, 2011 41
Figure 26: Athlete's Foot Therapeutics - Clinical Trials by Status, 2011 42
Figure 27: Athlete's Foot Therapeutics - Prominent Sponsors, 2011 43
Figure 28: Athlete's Foot Therapeutics - Overall Sponsors, 2011 44
Figure 29: Athlete's Foot Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2011 45
Figure 30: Athlete's Foot Therapeutics Market - Drivers and Barriers, 2011 46
Figure 31: Implications for Future Market Competition in the Athlete's Foot Market, 2011 47
Figure 32: Athlete's Foot Therapeutics Market - Pipeline by Company, 2011 48
Figure 33: GlobalData Market Forecasting Model 57
Companies mentioned
Quinnova Pharmaceuticals, Inc.
Nitric Biotherapeutics, Inc.
Anacor Pharmaceuticals, Inc.
To order this report:
: Athlete's Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
